about
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma.Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion.FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer.Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis.Cyclooxygenase-2 Gly587Arg variant is associated with differential enzymatic activity and risk of esophageal squamous-cell carcinoma.Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma.Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.Progress and challenges in HER2-positive gastroesophageal adenocarcinomaHaplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progressionRole of CD14 promoter polymorphisms in Helicobacter pylori infection--related gastric carcinomaInteraction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer
P50
Q33804713-7EF4BF88-F603-4D1E-8DE5-2423C397B0AEQ34252852-50A186E8-F766-43B3-957D-74C76A73DB0EQ36385589-8982F22F-7D73-4870-BB04-8B7D5FF19E7EQ36403535-33E7EA32-E562-4594-9F84-BC379B7052C9Q39697736-9D2E2020-B9C9-4565-89E0-4DAD3BE926AAQ39986291-80C88DC6-9B04-48D9-8613-EF6DFD86D433Q46060538-96519A55-C414-487E-9ED7-7E82C385CC78Q46083015-6D9647EF-52A2-4339-9C62-01FEAD01681DQ53334125-48C05F5C-36E2-4DE5-9915-9200B110B720Q54365633-70C0DB64-3545-4A1D-9D38-6046B58F3E66Q64052649-DA710901-F76A-4EEE-8515-62561A0322ABQ79405024-B5EAD881-23FC-4F3E-B7A7-9CD2F8EC2A3BQ80166974-D458F9E2-EFFD-431A-A4CC-64678A367D93Q80635954-7F3FABEF-5A9B-42D9-ACE8-999E62150D03
P50
description
researcher (ORCID 0000-0001-7066-9058)
@en
name
Dan Zhao
@en
Dan Zhao
@nl
type
label
Dan Zhao
@en
Dan Zhao
@nl
prefLabel
Dan Zhao
@en
Dan Zhao
@nl
P108
P108
P31
P496
0000-0001-7066-9058